Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 79

Related Citations for PubMed (Select 22884969)

1.

Acute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients.

Yang C, Zhou ZQ, Gao ZQ, Shi JY, Yang JJ.

Biol Psychiatry. 2013 Jun 15;73(12):e35-6. doi: 10.1016/j.biopsych.2012.07.022. Epub 2012 Aug 9. No abstract available.

PMID:
22884969
2.

Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.

Denk MC, Rewerts C, Holsboer F, Erhardt-Lehmann A, Turck CW.

Am J Psychiatry. 2011 Jul;168(7):751-2. doi: 10.1176/appi.ajp.2011.11010128. No abstract available.

PMID:
21724677
3.

Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression.

Joaquim HP, Talib LL, Forlenza OV, Diniz BS, Gattaz WF.

J Psychiatr Res. 2012 Aug;46(8):1053-8. doi: 10.1016/j.jpsychires.2012.04.020. Epub 2012 May 22.

PMID:
22622071
4.

Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps.

Wang L, Wang X, Proud CG.

Am J Physiol Heart Circ Physiol. 2000 Apr;278(4):H1056-68.

5.

Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties.

Zunszain PA, Horowitz MA, Cattaneo A, Lupi MM, Pariante CM.

Mol Psychiatry. 2013 Dec;18(12):1236-41. doi: 10.1038/mp.2013.87. Epub 2013 Jul 23. Review.

6.
7.

Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.

Réus GZ, Stringari RB, Ribeiro KF, Ferraro AK, Vitto MF, Cesconetto P, Souza CT, Quevedo J.

Behav Brain Res. 2011 Aug 1;221(1):166-71. doi: 10.1016/j.bbr.2011.02.024. Epub 2011 Mar 21.

PMID:
21397634
8.

Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.

Liu JR, Baek C, Han XH, Shoureshi P, Soriano SG.

Br J Anaesth. 2013 Jun;110 Suppl 1:i3-9. doi: 10.1093/bja/aet057. Epub 2013 Mar 26.

10.

Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice.

Beurel E, Song L, Jope RS.

Mol Psychiatry. 2011 Nov;16(11):1068-70. doi: 10.1038/mp.2011.47. Epub 2011 Apr 19. No abstract available.

11.

Mechanism of zinc-induced phosphorylation of p70 S6 kinase and glycogen synthase kinase 3beta in SH-SY5Y neuroblastoma cells.

An WL, Bjorkdahl C, Liu R, Cowburn RF, Winblad B, Pei JJ.

J Neurochem. 2005 Mar;92(5):1104-15.

PMID:
15715661
12.

Identification of eukaryotic elongation factor-2 as a novel cellular target of lithium and glycogen synthase kinase-3.

Karyo R, Eskira Y, Pinhasov A, Belmaker R, Agam G, Eldar-Finkelman H.

Mol Cell Neurosci. 2010 Dec;45(4):449-55. doi: 10.1016/j.mcn.2010.08.004. Epub 2010 Aug 12.

PMID:
20708687
13.

Nerve and epidermal growth factor induce protein synthesis and eIF2B activation in PC12 cells.

Kleijn M, Welsh GI, Scheper GC, Voorma HO, Proud CG, Thomas AA.

J Biol Chem. 1998 Mar 6;273(10):5536-41.

14.

Long-term effects of rapamycin treatment on insulin mediated phosphorylation of Akt/PKB and glycogen synthase activity.

Varma S, Shrivastav A, Changela S, Khandelwal RL.

Exp Cell Res. 2008 Apr 1;314(6):1281-91. doi: 10.1016/j.yexcr.2007.12.019. Epub 2008 Jan 5.

PMID:
18261725
15.
16.

Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3beta and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation.

Nemoto T, Satoh S, Maruta T, Kanai T, Yoshikawa N, Miyazaki S, Yanagita T, Wada A.

Neuropharmacology. 2010 Jun;58(7):1097-108. doi: 10.1016/j.neuropharm.2010.01.018. Epub 2010 Feb 6.

PMID:
20144629
17.

Glycogen synthase kinase 3beta is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells.

Mariappan MM, Shetty M, Sataranatarajan K, Choudhury GG, Kasinath BS.

J Biol Chem. 2008 Nov 7;283(45):30566-75. doi: 10.1074/jbc.M801756200. Epub 2008 Aug 12.

18.

Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia.

Okamoto N, Nakai T, Sakamoto K, Nagafusa Y, Higuchi T, Nishikawa T.

J ECT. 2010 Sep;26(3):223-7. doi: 10.1097/YCT.0b013e3181c3b0aa.

PMID:
19935085
19.

Scopolamine and ketamine: evidence of convergence?

Monteggia LM, Kavalali ET.

Biol Psychiatry. 2013 Nov 15;74(10):712-3. doi: 10.1016/j.biopsych.2013.08.011. No abstract available.

PMID:
24144324
20.

Ketamine and the potential role for rapid-acting antidepressant medications.

Krystal JH.

Swiss Med Wkly. 2007 Apr 21;137(15-16):215-6. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk